Being seen at a pancreatic center of excellence is key. I live near NYC or no difficulty with being seen at a top pancreatic center of excellence. A local oncologist is a good start, but wouldn't accept as definitive. I helped my brother research for resources in North Carolina. Because of my history of pancreatic cancer and BRCA, and his status as a BRCA carrier, I encouraged him to pursue screening. He started by seeing a local gastroenterologist who did an endoscopic ultrasound. The gastroenterologist suggested a follow up CT for screening. I do not see anywhere that CT is advised for screening for pancreatic cancer (repeated radiation exposure) so I have encouraged him to seek a higher level of care for ongoing screening. The closest center of excellence to his home is Duke University. We looked through the gastroenterologists to see who might have the needed expertise and found two with an interest in pancreatic cystic disease and screening high risk individuals. Definitely need to do your own research in seeking experts. Sometimes a local doctor will know where you can go in your area so worth seeing what the oncologist suggests.

I think everyone who participates in this forum would agree about the importance of finding the best resource you can access. The group can give feedback on their own personal experiences. Hope you will find an expert to help you. Self advocacy is essential!

Some resources:
Listing of 155 National Pancreatic Foundation accredited center of excellence
https://pancreasfoundation.org/patient-resources/
Pancreatic Cancer Action Network
Can call or contact on line and they will be able to help find resources local to you
https://pancan.org/facing-pancreatic-cancer/patient-services/contact-us/
American Gastroenterological Association
Guidelines for Screening for Pancreatic Cancer
https://gastro.org/clinical-guidance/pancreas-cancer-screening-in-high-risk-individuals/
National Library of Medicine
Scientific review of the topic of screening
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390120/#:~:text=Screening%20of%20patients%20with%20IPMN,%2Dderived%20and%20%2Dconcomitant%20PDAC.
TOP CENTERS
Memorial Sloan Kettering Cancer Center, New York City New York
https://www.mskcc.org/cancer-care/types/pancreatic-cysts/treatment/pancreatic-cyst-surveillance
New York University Langone, New York City, New York
https://nyulangone.org/locations/pancreatic-cancer-center/pancreatic-cancer-early-detection-prevention-center
Mayo Clinic, Rochester Minnesota
https://www.mayo.edu/research/centers-programs/pancreatic-cancer-early-detection-research-program/overview
Johns Hopkins University, Baltimore Maryland
https://www.hopkinsmedicine.org/health/conditions-and-diseases/pancreatic-cancer/pancreatic-cancer-screening
Massachusetts General Hospital, Boston Massachusetts
https://advances.massgeneral.org/digestive-health/video.aspx?id=1132
MD Andersen Cancer Center, Houston, Texas
https://www.mdanderson.org/patients-family/diagnosis-treatment/care-centers-clinics/gastrointestinal-cancer-center/pancreatic-cyst-clinic.html
Pancreatic Cancer Early Detection Consortium
https://precedestudy.org/
Any one of the 30 participating centers should be a good bet for an especially strong center. The participating centers are listed on the home page

The Pancreatic Cancer Early Detection (PRECEDE) Consortium is an international, multi-institutional collaborative group of experts to increase survival for pancreatic cancer patients by improving early detection, screening, risk modeling and prevention for those with a heritable risk for pancreatic cancer, through a novel model of collaboration and data sharing. PRECEDE’s mission is to transform the early detection and prevention of pancreatic cancer, with the aim of increasing the 5-year survival rate from 10% to 50% within the next 10 years. With over 30 leading academic medical centers across the globe, PRECEDE has assembled the largest high-risk patient cohort, with longitudinal clinical data and biospecimen acquisition and tracking.